Drugs / Cathflo Activase
Regulatory milestones approvals, filings & regulatory actions · 5 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (4) | US (FDA) | ACTIVASE | — | 1995-04-03 – 2005-01-04 | fda.gov ↗ |
| Approved | US (FDA) | ACTIVASE | — | 1987-11-13 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04806373 | Jun 2021 → Dec 2023 | — | Memorial Healthcare System | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cathflo Activase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04806373 ↗ |
| Route | Other | “given through chest pleural catheter” NCT04806373 ↗ |